News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Middle East airspace closures force major carriers to extend cancellations and cut routes, worsening global flight disruptions and schedules.
  • Hostilities threaten civilian infrastructure and refrigerated drug routes, raising risks of oncology medicine shortages and longer transit times.
  • Pentagon declines to reaffirm NATO mutual-defense pledge, saying presidential decision will determine U.S. response to allied actions.
  • Constellation Energy warns 2026 EPS guidance below Street expectations and shares fall about 7% after the update.
  • Raymond James flags National Bank of Canada as most exposed to volatile trading revenue among Canada's six largest banks.
  • Nvidia and Meta lead market gains while energy and healthcare names slide, producing volatile cross-cap leadership in Tuesday trading.

Latest Articles

Baird Starts Coverage of Caris Life Sciences With Outperform Rating

Baird Starts Coverage of Caris Life Sciences With Outperform Rating

Baird has launched coverage of Caris Life Sciences (NASDAQ: CAI) with an outperform rating and a $26 price target, implying roughly 26% upside from the current share price. The initiation comes amid a steep share-price decline over the past six months, while preliminary fourth-quarter and full-year 2025 results topped analyst and FactSet consensus.

Agility Global Posts Quarterly Beat Driven by Large One-Off Gains

Agility Global Posts Quarterly Beat Driven by Large One-Off Gains

Agility Global reported fourth-quarter 2025 results that outperformed consensus, with revenue rising to $1.42 billion and headline profitability lifted by substantial one-off gains. While statutory EBITDA and net income far exceeded analyst expectations, adjusted results excluding one-time items were more modest and missed some sell-side forecasts.

Baird Starts Coverage of Tempus AI With Outperform, Sees Modest Upside as Firm Highlights Data-and-AI Strategy

Baird Starts Coverage of Tempus AI With Outperform, Sees Modest Upside as Firm Highlights Data-and-AI Strategy

Baird has begun formal coverage of Tempus AI Inc (NASDAQ:TEM), assigning an Outperform rating with a $59.00 price objective, roughly 14% above the current share price of $51.95. The research note accompanies a Speculative Risk designation and comes as Tempus reports preliminary, unaudited commercial milestones including a record total contract valu…

Baird Starts Coverage on Guardant Health With Outperform, Sets $120 Target

Baird Starts Coverage on Guardant Health With Outperform, Sets $120 Target

Baird has begun coverage of Guardant Health (NASDAQ: GH) with an Outperform rating and a $120 price target, implying roughly 14% upside from the prevailing share price. The firm attached a Speculative Risk designation to the call and highlighted Guardant’s position in therapy-selection testing and pipeline optionality, while noting concerns about S…

EU Regulators Intensify Scrutiny of Major Tech Firms Across Multiple Fronts

EU Regulators Intensify Scrutiny of Major Tech Firms Across Multiple Fronts

European competition and digital regulators have opened a wide range of investigations and levied sizeable fines against leading technology companies. The cases cover alleged anticompetitive conduct in online advertising and app stores, breaches of new digital rules, questions over access to data for AI use, and content-related compliance under rec…

Citizens Commences Coverage on Immutep, Flags Efti’s Potential in NSCLC

Citizens Commences Coverage on Immutep, Flags Efti’s Potential in NSCLC

Citizens initiated coverage of Immutep Limited (NASDAQ: IMMP) with a Market Outperform rating and a $6 price target, pointing to substantial upside from the stock's recent price of $2.64. The analyst cited clinical data supporting efti's immunostimulatory activity, an ongoing Phase 3 NSCLC trial, and a solid cash position, while noting valuation an…

Regulators Worldwide Target Grok Over Sexualised AI Deepfakes

Regulators Worldwide Target Grok Over Sexualised AI Deepfakes

Governments and regulatory bodies across multiple continents have initiated investigations, orders and access restrictions in response to reports that Grok, the AI chatbot developed by xAI and hosted on X, can produce sexually explicit or manipulated images, including material involving minors. Actions range from formal probes and evidence-preserva…

UBS Elevates SSP Group to Buy, Cites Sharper Cash-Flow Trajectory

UBS Elevates SSP Group to Buy, Cites Sharper Cash-Flow Trajectory

UBS has raised its rating on SSP Group Plc. to Buy from Neutral and increased its price target to GBP2.45 from GBP1.80, flagging an improved outlook for cash generation and several potential upside catalysts alongside recently reported stronger financial results for the second half of 2025. The bank projects material free cash flow growth through 2…

Spain Instructs Prosecutors to Investigate X, Meta and TikTok Over Alleged AI-Created Child Sexual Abuse Material

Spain Instructs Prosecutors to Investigate X, Meta and TikTok Over Alleged AI-Created Child Sexual Abuse Material

The Spanish government has asked prosecutors to examine whether social media platforms X, Meta and TikTok have been used to create and disseminate child sexual abuse material generated with artificial intelligence, Prime Minister Pedro Sanchez said. The move fits into a broader European push to address abusive and potentially illegal uses of AI and…